Skip to content

To Study the Effectiveness of Homoeopathic Medicine in the Management of Acne Vulgaris Among Adults

Effectiveness of Individualized Homoeopathic Medicine in Fifty Millesimal Potency in the Management of Acne Vulgaris Among Adults An Experimental Non Controlled Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095915
Enrollment
34
Registered
2025-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Homoeopathic management: Homoeopathic management with individualized homoeopathic medicine in fifty millesimal potency. Total Duration of Study is 18 months. Each case will be studied f

Sponsors

Dr Yuvraj Shamrao Patgavkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of adult age group. Patients presented with acne vulgaris up to grade 3. Patients of all genders. Patient willing to give their free consent.

Exclusion criteria

Exclusion criteria: Patients with suspected other immunocompromised disease. Pregnant and lactating women. Patient presenting with acne scars only. Patients on any other line of treatment for Acne vulgaris or had taken any medication for acne in preceding 1 month. Patients presenting with Acne conglobata, Acne fulminans, Hidradenitis suppurativa

Design outcomes

Primary

MeasureTime frame
Outcome assessment will be done by applying global acne grading system score. The score for each area local score is calculated using formula Local score is factor multiplied by grade 0 to 4 Highest grade present on that particular area will be considered as grade. The global score is sum total of local score. The outcome assessment will be done on basis of pre and post treatment gags score Outcome will be assessed in terms of following criteria 76 percent to 100 percent reduction of lesion is excellent improvement 51 percent to 75 percent reduction of lesion is significant improvement 26 percent to 50 percent reduction of lesion is moderate improvement 1 percent to 25 percent reduction of lesion is mild improvement 0 percent reduction of lesion is no change Timepoint: Duration of study is 18 months. Duration of each case is each case will be studied for a period of 6 months or if remission occurs whichever is earlier. Duration of follow up is each case will be followed up at the interval of 15 days or as and when required. clinical assessment will be done at baseline, 3rd month and at the end of the treatment or 6th month, whichever is earlier.

Secondary

MeasureTime frame
NOT APPICABLETimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDR Sachin Y Chokakkar

Dr G D Pol Foundation Y M T Homoeopathic Medical College And P G Institute Hospital

newbeginingsach@yahoo.com9172488888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026